Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer

Fibrosing cholestatic hepatitis (FCH) is a variant of viral hepatitis reported in hepatitis B virus or hepatitis C virus infected liver, renal or bone transplantation recipients and in leukemia and lymphoma patients after conventional cytotoxic chemotherapy. FCH constitutes a well-described form of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2009-05, Vol.15 (18), p.2290-2292
Hauptverfasser:	Ceballos-Viro, Jaime, López-Picazo, José-M, Pérez-Gracia, José-L, Sola, Jesús-J, Aisa, Gregorio, Gil-Bazo, Ignacio
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Case Report Cholestasis, Intrahepatic - etiology Cholestasis, Intrahepatic - pathology Fatal Outcome Fibrosis - etiology Fibrosis - pathology Hepacivirus Hepatitis B virus Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Male Middle Aged Small Cell Lung Carcinoma - drug therapy Small Cell Lung Carcinoma - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!